EGFR and neoplasm: In the murine APCmin/+ model of colon cancer, it was established that the genetic deletion of ADAM17, which is responsible for generating not only sIL-6R but also soluble TNFα and soluble ligands of the epidermal growth factor receptor (EGFR), resulted in completely abrogated tumour development16.